Company Overview

Update
Founded:
2007
Founders:
Jin-Long Chen
Headquarters:
South San Francisco, CA
Funding:
$144.90M
Categories:
Biotechnology, Medical

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

Description

Update

NGM Biopharmaceuticals, Inc. is a privately held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the Company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. Our current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.

Current Team (10)

Update

Board Members and Advisors (2)

Update

Funding Rounds (4) - $144.90M

Update

Investors (6)

Update

Offices/Locations (1)

Update
  • Office

    630 Gateway Blvd

    South San Francisco, CA 94080-7014

    USA

Images (1)

Update
  • A015666a5ef687fc2f22a565a60efcb7